Antitumor activity of Type I and Type III interferons in BNL hepatoma model

Hepatocellular carcinoma (HCC) occurs most commonly secondary to cirrhosis due to chronic hepatitis C or B virus (HCV/HBV) infections. Type I interferon (IFN-α) treatment of chronic HCV/HBV infections reduces the incidence of HCC in cirrhotic patients. However, IFN-α toxicity limits its tolerability...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Immunol Immunother
Päätekijät: Abushahba, Walid, Balan, Murugabaskar, Castaneda, Ismael, Yuan, Yao, Reuhl, Kenneth, Raveche, Elizabeth, de la Torre, Andrew, Lasfar, Ahmed, Kotenko, Sergei V.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer-Verlag 2010
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4699672/
https://ncbi.nlm.nih.gov/pubmed/20217081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-010-0831-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia